Pharmaniaga Berhad (KLSE:PHARMA)

Market Cap	1.61B +384.6%
Revenue (ttm)	3.93B +4.5%
Net Income	48.51M -63.2%
EPS	0.01 -85.4%
Shares Out	6.56B
PE Ratio	18.28
Forward PE	15.31
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,176,500
Average Volume	15,121,520
Open	0.2450
Previous Close	0.2450
Day's Range	0.2400 - 0.2450
52-Week Range	0.1300 - 0.3400
Beta	0.99
RSI	44.71
Earnings Date	May 15, 2026

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; and supply, trading, and installation of medical and hospital equipment. The company also manufactures and sells generic drugs; conducts research and development of pharmaceutic...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1994
• Employees: 3,502
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: PHARMA

Financial Performance

In 2025, Pharmaniaga Berhad's revenue was 3.93 billion, an increase of 4.48% compared to the previous year's 3.76 billion. Earnings were 48.51 million, a decrease of -63.20%.